Related Experiment Video
Updated: Jul 15, 2025
Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting
Published on: March 25, 2019
Recent Insights into Nanotechnology in Colorectal Cancer
Aram Asareh Zadegan Dezfuli1, Mohammed Abu-Elghait2, Salem S Salem3
1Department of Microbiology, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. aramasareh836@yahoo.com.
Abstract:
Colorectal cancer (CRC) is the third cancer among the known causes of cancer that impact people. Although CRC drug options are imperfect, primary detection of CRC can play a key role in treating the disease and reducing mortality. Cancer tissues show many molecular markers that can be used as a new way to advance therapeutic methods. Nanotechnology includes a wide range of nanomaterials with high diagnostic and therapeutic power. Several nanomaterials and nanoformulations can be used to treat cancer, especially CRC. In this review, we discuss recent insights into nanotechnology in colorectal cancer.
Insights
Early detection of colorectal cancer (CRC) is crucial for treatment. Nanotechnology offers promising nanomaterials for advanced CRC diagnosis and therapy, improving patient outcomes.
Area of Science:
- Oncology
- Nanomedicine
- Materials Science
Background:
- Colorectal cancer (CRC) is a leading cause of cancer mortality worldwide.
- Current CRC treatment options have limitations, highlighting the need for novel therapeutic strategies.
- Early detection significantly improves CRC patient prognosis and survival rates.
Purpose of the Study:
- To review recent advancements in nanotechnology for colorectal cancer (CRC) diagnosis and treatment.
- To explore the potential of nanomaterials in developing innovative therapeutic approaches for CRC.
- To discuss the diagnostic and therapeutic capabilities of nanotechnology in the context of CRC.
Main Methods:
- Comprehensive literature review of recent studies on nanotechnology applications in CRC.
- Analysis of various nanomaterials and nanoformulations investigated for CRC.
- Synthesis of current knowledge on nanotechnology-based diagnostic and therapeutic strategies for CRC.
Main Results:
- Nanomaterials exhibit significant potential for early and accurate diagnosis of CRC.
- Various nanoformulations demonstrate promising therapeutic efficacy against CRC.
- Nanotechnology facilitates targeted drug delivery and enhanced treatment outcomes in CRC models.
Conclusions:
- Nanotechnology presents a transformative approach to colorectal cancer management.
- Further research into nanomaterials can lead to improved diagnostic tools and more effective CRC therapies.
- Integrating nanotechnology into clinical practice holds promise for reducing CRC-related mortality.
